MegaMD Co., Ltd. (KOSDAQ:133750)

MegaMD Statistics

Total Valuation

MegaMD has a market cap or net worth of KRW 40.15 billion. The enterprise value is 9.45 billion.

Market Cap	40.15B
Enterprise Value	9.45B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

MegaMD has 22.07 million shares outstanding.

Current Share Class	22.07M
Shares Outstanding	22.07M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.40%
Owned by Institutions (%)	n/a
Float	10.55M

Valuation Ratios

The trailing PE ratio is 12.90.

PE Ratio	12.90
Forward PE	n/a
PS Ratio	1.14
PB Ratio	0.61
P/TBV Ratio	0.65
P/FCF Ratio	10.21
P/OCF Ratio	8.07
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.33, with an EV/FCF ratio of 2.40.

EV / Earnings	3.01
EV / Sales	0.27
EV / EBITDA	1.33
EV / EBIT	4.64
EV / FCF	2.40

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.05.

Current Ratio	2.00
Quick Ratio	1.93
Debt / Equity	0.05
Debt / EBITDA	0.54
Debt / FCF	0.86
Interest Coverage	5.18

Financial Efficiency

Return on equity (ROE) is 4.84% and return on invested capital (ROIC) is 1.06%.

Return on Equity (ROE)	4.84%
Return on Assets (ROA)	0.83%
Return on Invested Capital (ROIC)	1.06%
Return on Capital Employed (ROCE)	1.71%
Revenue Per Employee	246.11M
Profits Per Employee	21.97M
Employee Count	143
Asset Turnover	0.41
Inventory Turnover	40.52

Taxes

In the past 12 months, MegaMD has paid 896.59 million in taxes.

Income Tax	896.59M
Effective Tax Rate	22.21%

Stock Price Statistics

The stock price has decreased by -7.56% in the last 52 weeks. The beta is 0.67, so MegaMD's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-7.56%
50-Day Moving Average	1,960.38
200-Day Moving Average	2,147.75
Relative Strength Index (RSI)	19.16
Average Volume (20 Days)	78,350

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MegaMD had revenue of KRW 35.19 billion and earned 3.14 billion in profits. Earnings per share was 141.00.

Revenue	35.19B
Gross Profit	20.89B
Operating Income	1.16B
Pretax Income	4.04B
Net Income	3.14B
EBITDA	6.23B
EBIT	1.16B
Earnings Per Share (EPS)	141.00

Balance Sheet

The company has 34.09 billion in cash and 3.39 billion in debt, giving a net cash position of 30.70 billion or 1,390.82 per share.

Cash & Cash Equivalents	34.09B
Total Debt	3.39B
Net Cash	30.70B
Net Cash Per Share	1,390.82
Equity (Book Value)	65.67B
Book Value Per Share	2,974.74
Working Capital	18.70B

Cash Flow

In the last 12 months, operating cash flow was 4.97 billion and capital expenditures -1.04 billion, giving a free cash flow of 3.93 billion.

Operating Cash Flow	4.97B
Capital Expenditures	-1.04B
Free Cash Flow	3.93B
FCF Per Share	178.25

Margins

Gross margin is 59.36%, with operating and profit margins of 3.29% and 8.93%.

Gross Margin	59.36%
Operating Margin	3.29%
Pretax Margin	11.47%
Profit Margin	8.93%
EBITDA Margin	17.69%
EBIT Margin	3.29%
FCF Margin	11.18%

Dividends & Yields

This stock pays an annual dividend of 60.00, which amounts to a dividend yield of 3.25%.

Dividend Per Share	60.00
Dividend Yield	3.25%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	42.17%
Buyback Yield	n/a
Shareholder Yield	3.20%
Earnings Yield	7.82%
FCF Yield	9.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MegaMD has an Altman Z-Score of 2.78 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.78
Piotroski F-Score	5